Patents by Inventor Christian Opitz

Christian Opitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11320438
    Abstract: Tryptophan degradation is a key metabolic pathway controlling immune reactions and evidence suggests that during cancer progression generation of tryptophan metabolites may be fundamental for immune escape promoting the malignant phenotype of cancer cells in an autocrine fashion. The present invention relates to methods of measuring mass tag labelled tryptophan and metabolites thereof and methods using the labelled molecules for monitoring in a subject the effectiveness of a treatment and of disease recurrence after treatment, for stratifying patients and for diagnosing suppression of an immune response in a subject.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: May 3, 2022
    Assignees: ELECTROPHORETICS LIMITED, RUPRECHT-KARLS-UNIVERSITAT, DKFZ DEUTSCHES KREBSFORSCHUNGSZENTRUM
    Inventors: Sasa Koncarevic, Karsten Kuhn, Peter Schulz-Knappe, Ian Hugo Pike, Christiane Opitz, Michael Platten
  • Patent number: 10189324
    Abstract: A method for coupling a motor vehicle having a trailer coupling to a coupling element of a trailer with at least partially automatic actuation of the motor vehicle based on data acquired by a surroundings sensor system, for example a surroundings sensor system of the motor vehicle is disclosed. A controlled change in level is carried out at an at least one axle by an air suspension system of the motor vehicle based on the acquired data. A control unit for carrying out the method is also disclosed.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: January 29, 2019
    Assignee: Continental Teves AG & Co. oHG
    Inventor: Christian Opitz
  • Publication number: 20180246118
    Abstract: Tryptophan degradation is a key metabolic pathway controlling immune reactions and evidence suggests that during cancer progression generation of tryptophan metabolites may be fundamental for immune escape promoting the malignant phenotype of cancer cells in an autocrine fashion. The present invention relates to methods of measuring mass tag labelled tryptophan and metabolites thereof and methods using the labelled molecules for monitoring in a subject the effectiveness of a treatment and of disease recurrence after treatment, for stratifying patients and for diagnosing suppression of an immune response in a subject.
    Type: Application
    Filed: October 31, 2016
    Publication date: August 30, 2018
    Applicants: ELECTROPHORETICS LIMITED, RUPRECHT-KARLS-UNIVERSITÄT, DKFZ DEUTSCHES KREBSFORSCHUNGSZENTRUM
    Inventors: Sasa Koncarevic, Karsten Kuhn, Peter Schulz-Knappe, Ian Hugo Pike, Christiane Opitz, Michael Platten
  • Publication number: 20180141397
    Abstract: A method for coupling a motor vehicle having a trailer coupling to a coupling element of a trailer with at least partially automatic actuation of the motor vehicle based on data acquired by a surroundings sensor system, for example a surroundings sensor system of the motor vehicle is disclosed. A controlled change in level is carried out at an at least one axle by an air suspension system of the motor vehicle based on the acquired data. A control unit for carrying out the method is also disclosed.
    Type: Application
    Filed: January 16, 2018
    Publication date: May 24, 2018
    Applicant: Continental Teves AG & Co. oHG
    Inventor: Christian Opitz
  • Patent number: 9593062
    Abstract: The present invention relates to the field of cancer therapeutics and treatment of cancer. In particular, it relates to a method for treating and/or preventing a natural AHR ligand-dependent cancer comprising administering to a subject suffering from said cancer a therapeutically effective amount of an AHR inhibitor. Moreover, contemplated is a AHR inhibitor for use in treating and/or preventing a natural AHR ligand-dependent cancer.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: March 14, 2017
    Assignee: DEUTSCHLAND KREBSFORSCHUNGSZENTRUM
    Inventors: Michael Platten, Christiane Opitz, Wolfgang Wick, Ulrike Litzenburger
  • Publication number: 20140294860
    Abstract: The present invention relates to the field of cancer therapeutics and treatment of cancer. In particular, it relates to a method for treating and/or preventing a natural AHR ligand-dependent cancer comprising administering to a subject suffering from said cancer a therapeutically effective amount of an AHR inhibitor. Moreover, contemplated is a AHR inhibitor for use in treating and/or preventing a natural AHR ligand-dependent cancer.
    Type: Application
    Filed: September 7, 2012
    Publication date: October 2, 2014
    Applicant: Deutsches Krebsforschungszentrum
    Inventors: Michael Platten, Christiane Opitz, Wolfgang Wick, Ulricke Litzenburger
  • Patent number: 7100605
    Abstract: The invention relates to a therapy device for the specifically local treatment and curing of colds in the region of the nose, frontal sinus and throat area in human beings. The external appearance of the therapy device can resemble that of a common hair dryer or face sauna, but the therapy device also contains a means for reducing or suppressing HF radiation (electrosmog) which is normally emitted towards the external environment. According to the invention, a body made of crystallized salt, especially from a natural source, resulting in negative ionization of the heated air flow, is arranged in the region of the heated air flow prior to the exit thereof from the small, handy device. The body is cross-flown by the heated air flow or is at least touched thereby. The treatment of colds with the aid of said therapy device is based on the fact that cold viruses, i.e., primarily rhino viruses and corona viruses, can be eliminated by active treatment with a heated air flow.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: September 5, 2006
    Assignee: Vitaya Patent GmbH
    Inventor: Christian Opitz
  • Publication number: 20050150501
    Abstract: The invention relates to a therapy device for the specifically local treatment and curing of colds in the region of the nose, frontal sinus and throat area in human beings. The external appearance of the therapy device can resemble that of a common hair dryer or face sauna, but the therapy device also contains a means for reducing or suppressing HF radiation (electrosmog) which is normally emitted towards the external environment. According to the invention, a body made of crystallized salt, especially from a natural source, resulting in negative ionization of the heated air flow, is arranged in the region of the heated air flow prior to the exit thereof from the small, handy device. The body is cross-flown by the heated air flow or is at least touched thereby. The treatment of colds with the aid of said therapy device is based on the fact that cold viruses, i.e., primarily rhino viruses and corona viruses, can be eliminated by active treatment with a heated air flow.
    Type: Application
    Filed: April 25, 2003
    Publication date: July 14, 2005
    Inventor: Christian Opitz
  • Patent number: 5810987
    Abstract: A method for the electrophoretic dip coating of small parts and bulk goods aving an electrically conducting surface wherein the items to be coated are placed in a single layer onto a support which may be electrically conducting or nonconducting. During immersion, the surface contact locations are changed between the items to be coated themselves and the surface contact locations between the items and the support.
    Type: Grant
    Filed: December 27, 1996
    Date of Patent: September 22, 1998
    Assignee: SEP Gesellschaft fur technische Studien Entwicklung Planung mbH
    Inventor: Christian Opitz